ISHAGE-based single-platform flowcytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products:: CD34/CD133 selected or CD3/CD19 depleted stem cells, DLI and purified CD56+CD3- NK cells

被引:27
|
作者
Koehl, U. [1 ]
Bochennek, K. [1 ]
Esser, R. [1 ]
Brinkmann, A. [1 ]
Quaritsch, R. [1 ]
Becker, M. [1 ]
Soerensen, J. [1 ]
Bader, P. [1 ]
Schwabe, D. [1 ]
Klingebiel, T. [1 ]
Fischer, J. [2 ]
Zimmermann, S. Y. [1 ]
机构
[1] Univ Hosp Frankfurt, Lab Stem Cell Transplantat & Immunotherapy, D-60596 Frankfurt, Germany
[2] Inst Diagnost Transplantat & Cell Therapy, Dusseldorf, Germany
关键词
DLI; graft engineering; residual T cells; single-platform method;
D O I
10.1007/s12185-007-0018-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Considering the growing use of immunotherapeutic strategies in paediatric stem cell transplantation associated with risk of graft-versus-host disease, an accurate method for the enumeration of residual T cells/kg recipient's body weight is of paramount importance. Therefore, we propose a multi colour-flow cytometric strategy for correct absolute vital T cell enumeration in manipulated cell preparations for clinical use. The gating strategy is based on the ISHAGE single-platform stem cell enumeration method in combination with experiences from lymphocyte subtyping, using low scatter, high expression of CD3 and CD45 antigens and 7-AAD staining in a no-wash-preparation with counting beads. In spiking experiments, the detection limit was determined to be at 0.7 +/- 0.5 CD3(+) cells/mu l with a minimum of 50 T cell events acquired. The cell preparations analysed contained a median absolute CD3(+) T cell number of 221 x 10(3) (0.09%, CD34 selected grafts, n = 187), 900 x 10(3) (0.004%, CD3/CD19 depleted grafts, n = 15) and 283 x 10(3) (0.012%, CD3 depleted/CD56 enriched NK-cells, n = 14), respectively. The results differed of those from conventional T cell measurement in cell products after extensive manipulation. Our method provides reliable residual T cell enumeration even at extremely low concentrations.
引用
收藏
页码:98 / 105
页数:8
相关论文
共 25 条
  • [1] ISHAGE-based single-platform flowcytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products: CD34/CD133 selected or CD3/CD19 depleted stem cells, DLI and purified CD56+CD3− NK cells
    U. Koehl
    K. Bochennek
    R. Esser
    A. Brinkmann
    R. Quaritsch
    M. Becker
    J. Soerensen
    P. Bader
    D. Schwabe
    T. Klingebiel
    J. Fischer
    S. Y. Zimmermann
    International Journal of Hematology, 2008, 87 : 98 - 105
  • [2] Ishage-based single-platform flowcytometric analysis for detection of absolute viable T cells in fresh or cryopreserved products CD34 or CD133 selected or CD3 and CD19 depleted stem cells, DLI and highly purified CD56posCD3neg NK cells.
    Munkelt, D.
    Zimmermann, S.
    Bochennek, K.
    Esser, R.
    Brinkmann, A.
    Quaritsch, R.
    Becker, M.
    Soerensen, J.
    Bader, P.
    Schwabe, D.
    Klingebiel, T.
    Koehl, U.
    CYTOTHERAPY, 2006, 8
  • [3] Enumeration of residual T-cells in CD34 selected or CD3/CD19 depleted stem cell as well as NK preparations using 4-and 5-colour single-platform flowcytometric analysis
    Esser, R.
    Zimmermann, S. Y.
    Becker, M.
    Bochennek, K.
    Brinkmann, A.
    Quaritsch, R.
    Erben, S.
    Huenecke, S.
    Kloess, S.
    Munkelt, D.
    Jarisch, A.
    Soerensen, J.
    Bader, P.
    Fischer, J.
    Schwabe, D.
    Klingebiel, T.
    Koehl, U.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S332 - S333
  • [4] Analysis of the Recovery of Cryopreserved and Thawed CD34 and CD3 Cells
    Fisher, V. R.
    David-Ocampo, V.
    Byrne, K. M.
    Khuu, H.
    Stroncek, D. F.
    TRANSFUSION, 2012, 52 : 39A - 39A
  • [5] T-cell recovery after transplantation of CD3/CD19 depleted haploidentical stem cells in children
    Lang, P.
    Teltschik, H.
    Mueller, I.
    Schumm, M.
    Pfeiffer, M.
    Feuchtinger, T.
    Handgretinger, R.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S289 - S289
  • [6] Specific focusing on CD34 and CD3 viable cells from entire CD45 thawed population is more informative value for cryopreserved HSC and T cells recovery
    Varda-Bloom, N.
    Panshin, J.
    Avda, S.
    Teihman, S.
    Vemitsky, H.
    Spaniev, M.
    Bielorai, B.
    Toren, A.
    Shimoni, A.
    Amariglio, N.
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S348 - S348
  • [7] Haplo-identical stem cell transplantation with CD3/CD19 depleted stem cells: analysis of activity and recovery of co-transfused NK cells
    Lang, P.
    Teltschik, H.
    Pfeiffer, M.
    Mueller, I.
    Feuchtinger, T.
    Schumm, M.
    Ebinger, M.
    Handgretinger, R.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S43 - S43
  • [8] T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecific tetravalent antibody CD19 × CD3 or CD19 × CD16
    Lisa M. Pörtner
    Kathrin Schönberg
    Maryam Hejazi
    Daniela Brünnert
    Frank Neumann
    Lars Galonska
    Uwe Reusch
    Melvyn Little
    Rainer Haas
    Markus Uhrberg
    Cancer Immunology, Immunotherapy, 2012, 61 : 1869 - 1875
  • [9] A randomized trial comparing CD34 enriched grafts versus CD3/CD19 depleted grafts in partial T-cell depleted allogeneic stem cell transplantation
    Schaap, N.
    Eissens, D.
    Preijers, F.
    van der Meer, A.
    Schattenberg, A.
    Dolstra, H.
    van der Velden, W.
    de Witte, T.
    Smits, M.
    Blijlevens, N. M. A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S76 - S76
  • [10] T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecific tetravalent antibody CD19 x CD3 or CD19 x CD16
    Poertner, Lisa M.
    Schoenberg, Kathrin
    Hejazi, Maryam
    Bruennert, Daniela
    Neumann, Frank
    Galonska, Lars
    Reusch, Uwe
    Little, Melvyn
    Haas, Rainer
    Uhrberg, Markus
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (10) : 1869 - 1875